Wednesday, September 16, 2026Latest filing Sep 14, 2026

Daniel Goldman Periodic Transaction Report

Filed Sep 17, 2023 · House Clerk · 2 transactions

U.S. Representative · D · NY-10 · All trades by Daniel Goldman

On September 17, 2023, Rep. Daniel Goldman (D-NY-10) filed a periodic transaction report with the House Clerk disclosing 2 transactions (2 sales) dated Aug 3, 2023.

The filing covers 2 tickers, including $SIGCY, $WTKWY.

Reported amount ranges sum to $2K–$30K. Congress reports trade sizes in ranges, not exact figures.

Every trade was reported within the STOCK Act's 45-day window. The longest lag in this filing was 45 days.

Source document: House Clerk filing 20023677

Sample · the intelligence layer

Coldpine signal scoreA 0-1 composite from four weighted factors: disclosure speed, trade size, cluster activity (multiple members buying the same name), and the member’s track record. ≥ 0.65 is the high-conviction tier; ≥ 0.50 is moderate. Trades from trust-managed members are penalized (× 0.2 multiplier). It’s research, not a recommendation.

Daniel Goldman · Sold $SIGCY · Aug 3 · $1K–$15K

0.31LOW
Disclosure speedx 0.250.10
Trade sizex 0.250.20
Cluster activityx 0.150.00
Track recordx 0.350.67

Every disclosed trade in the database gets this treatment: a four-factor score and a written read from Coldpine’s AI-based analysis. Informational only, not investment advice. Create a free account for every scored trade →

Follow Daniel Goldman

Get an email the moment Daniel Goldman files the next one. Free, no card, no spam.

Follow free →
2
Transactions
0 / 2
Buys / sells
2
Tickers
45d
Longest lag

Tickers in this filing

Transactions disclosed

Trade dateTickerAssetTypeOwnerAmountLag
Aug 3, 2023SIGCYSIG GROUP AG UNSP/ADR (SIGCY)sell$1K–$15K45d
Aug 3, 2023WTKWYWolters Kluwer N V Ord American Depositary Shares (WTKWY)sell$1K–$15K45d

Other recent filings by Daniel Goldman

← All congressional filings, newest first

From Coldpine Research

Data parsed from the public STOCK Act filing linked above. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. Nothing here is a recommendation. See scores and Coldpine's read on every trade, free with an account →